Perform Another (Advanced) Search

1.  Study Posting (695) Trial #10092, Pancreatic Cancer, Houston, TX
...Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Adenocarcinoma Of The Pancreas Study the safety and possible effectiveness of antineoplastons in patients with incurable adenocarcinoma of the pancreas. Describe the patients' response, tolerance to, and the side effects of this regimen. Inclusion Criteria ...
View Page

2.  Study Posting (2246) Trial #129806, Pancreatic Cancer, Duarte, CA
...Cancer, Duarte, CA Trial Information ADV-TK Therapy in Combination with Surgery and Chemoradiation for Pancreas Cancer You have been asked to participate in this research study because you have cancer of the pancreas. This study is being done to evaluate a research approach that includes the transfer of ...
View Page

3.  Study Posting (4519) Trial #117370, Pancreatic Cancer, Zaragoza, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

4.  Study Posting (4519) Trial #113498, Pancreatic Cancer, Valencia, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

5.  Study Posting (4519) Trial #117426, Pancreatic Cancer, Sevilla, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

6.  Study Posting (4519) Trial #117369, Pancreatic Cancer, Santander, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

7.  Study Posting (4519) Trial #111958, Pancreatic Cancer, Sagunto, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

8.  Study Posting (4519) Trial #117410, Pancreatic Cancer, Sabadell, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

9.  Study Posting (4519) Trial #113497, Pancreatic Cancer, Pontevedra, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

10.  Study Posting (4519) Trial #117409, Pancreatic Cancer, Navarra, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

11.  Study Posting (4519) Trial #117412, Pancreatic Cancer, Murcia, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

12.  Study Posting (4519) Trial #128590, Pancreatic Cancer, Manresa, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

13.  Study Posting (4519) Trial #111443, Pancreatic Cancer, Madrid, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

14.  Study Posting (4519) Trial #111956, Pancreatic Cancer, Lugo, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

15.  Study Posting (4519) Trial #152792, Pancreatic Cancer, Lerida, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

16.  Study Posting (4519) Trial #117398, Pancreatic Cancer, Jaen, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

17.  Study Posting (4519) Trial #111903, Pancreatic Cancer, Guadalajara, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

18.  Study Posting (4519) Trial #117368, Pancreatic Cancer, Granada, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

19.  Study Posting (4519) Trial #117385, Pancreatic Cancer, Girona, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page

20.  Study Posting (4519) Trial #111724, Pancreatic Cancer, Elche, Spain
...of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship between Skin Toxicity and Survival Status: No longer recruiting Protocol Number: ML20296 Sponsor: Hoffmann ...
...study of Tarceva in combination with gemcitabine in unresectable and/or metastatic cancer of the pancreas : relationship between skin rash and survival Brief Summary: This single arm study will evaluate the ...
View Page